Role of Biosimilars in Expanding Treatment Accessibility

The global rheumatoid arthritis therapeutics market size is projected to reach US$ 53.91 billion by 2034 from US$ 31.08 billion in 2025. The market is anticipated to register a CAGR of 6.31% during the forecast period 2026-2034.

The report is categorized by Product Type (Pharmaceuticals, Biologics and biosimilars) and further analyzes the market based on Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies). A comprehensive breakdown is provided at global, regional, and country levels for each of these key segments.

Read More - https://www.theinsightpartners.....com/reports/rheumat